[144] IBEX Limited SEC Filing
IBEX Limited reported a proposed sale of 10,000 common shares through RBC Capital Markets with an approximate aggregate market value of $300,013. The filing states the shares represent stock grants acquired on 04/20/2022 from the issuer and that the sale is expected on 08/22/2025 on NASDAQ. The filing shows 13,372,404 shares outstanding, and no other sales by the reporting person in the past three months are reported. The filer also affirms they are not aware of any undisclosed material adverse information and notes the legal warning about intentional misstatements.
IBEX Limited ha segnalato la proposta di vendita di 10.000 azioni ordinarie tramite RBC Capital Markets, per un valore di mercato complessivo approssimativo di $300.013. La comunicazione indica che le azioni corrispondono a assegnazioni di azioni ricevute il 20/04/2022 dall'emittente e che la vendita 猫 prevista per il 22/08/2025 sul mercato NASDAQ. Il deposito riporta 13.372.404 azioni in circolazione e non segnala altre vendite da parte del dichiarante negli ultimi tre mesi. Il dichiarante inoltre afferma di non essere a conoscenza di informazioni riservate rilevanti non divulgate e richiama l'avviso legale relativo a dichiarazioni mendaci intenzionali.
IBEX Limited inform贸 una propuesta de venta de 10.000 acciones ordinarias a trav茅s de RBC Capital Markets, con un valor de mercado agregado aproximado de $300.013. La presentaci贸n indica que las acciones corresponden a concesiones de acciones recibidas el 20/04/2022 del emisor y que la venta est谩 prevista para el 22/08/2025 en NASDAQ. El informe muestra 13.372.404 acciones en circulaci贸n y no informa otras ventas por parte del declarante en los 煤ltimos tres meses. El presentador tambi茅n afirma no tener conocimiento de informaci贸n adversa material no divulgada y se帽ala la advertencia legal sobre declaraciones intencionalmente falsas.
IBEX Limited电� RBC Capital Markets毳� 韱淀暣 10,000 氤错喌欤�鞚� 毵り皝鞚� 鞝滌晥頄堨溂氅�, 齑� 鞁滌灔臧�旃樀鐢 鞎� $300,013鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐惖鐢 頃措嫻 欤检嫕鞚� 氚滍枆靷攵�韯� 2022雲� 4鞗� 20鞚检棎 靾橂牴頃� 欤检嫕 攵�鞐�鞐� 頃措嫻頃橂┌, 毵り皝鞚� 2025雲� 8鞗� 22鞚� NASDAQ鞐愳劀 鞚措（鞏挫 鞓堨爼鞚措澕瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊电� 鞙犿喌欤检嫕靾橁皜 13,372,404欤�鞛勳潉 氤挫棳欤茧┌, 氤搓碃鞚胳棎 鞚橅暅 斓滉芳 3臧滌洈 雮� 雼るジ 毵り皝鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖鞚胳潃 霕愴暅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橁碃, 瓿犾潣鞝� 項堨渼歆勳垹鞐� 甏�頃� 氩曥爜 瓴疥碃毳� 鞏戈笁頄堨姷雼堧嫟.
IBEX Limited a d茅clar茅 la vente propos茅e de 10 000 actions ordinaires via RBC Capital Markets, pour une valeur marchande agr茅g茅e d'environ 300 013 $. Le d茅p么t indique que les actions correspondent 脿 des attributions d'actions re莽ues le 20/04/2022 de l'茅metteur et que la vente est pr茅vue le 22/08/2025 sur le NASDAQ. Le dossier fait 茅tat de 13 372 404 actions en circulation et n'enregistre aucune autre vente par la personne d茅clarante au cours des trois derniers mois. Le d茅clarant affirme 茅galement ne pas 锚tre au courant d'informations d茅favorables mat茅rielles non divulgu茅es et rappelle l'avertissement l茅gal concernant les fausses d茅clarations intentionnelles.
IBEX Limited meldete einen vorgeschlagenen Verkauf von 10.000 Stammaktien 眉产别谤 RBC Capital Markets mit einem ungef盲hren Gesamtkurswert von $300.013. Die Einreichung gibt an, dass die Aktien Aktienschenkungen vom 20.04.2022 des Emittenten darstellen und der Verkauf voraussichtlich am 22.08.2025 an der NASDAQ stattfinden wird. Die Meldung weist 13.372.404 ausstehende Aktien aus und berichtet 眉产别谤 keine weiteren Verk盲ufe der meldenden Person in den letzten drei Monaten. Der Melder best盲tigt au脽erdem, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und weist auf die rechtliche Warnung betreffend vors盲tzliche Falschangaben hin.
- Full disclosure of the sale quantity, broker, acquisition date, and planned sale date
- Shares acquired as stock grants are identified, clarifying the source of the securities
- Attestation that the seller is not aware of undisclosed material adverse information
- None.
Insights
TL;DR Insider plans to sell a small block (鈮�0.075%) of shares; disclosure is routine and non-material.
The filing documents a proposed sale of 10,000 common shares valued at roughly $300,013 via a broker on NASDAQ. Given total outstanding shares of 13,372,404, the position represents about 0.075% of the float, which is immaterial to company valuation. The origin of the shares as a stock grant indicates this is likely a scheduled or opportunistic sale of vested equity rather than a company-financed transfer. The explicit representation regarding absence of undisclosed material information and the use of a broker reflect standard compliance practices.
TL;DR Filing meets Rule 144 disclosure requirements; no red flags regarding timing or disclosures.
This Form 144 provides required particulars: class, broker, quantity, value, acquisition details, and planned sale date. The shares were acquired via a stock grant from the issuer on 04/20/2022, and no recent sales are reported, reducing concerns about repeated insider dispositions. The signer鈥檚 attestation about material information and the included broker details align with best practice for transparency. There is no indication of undisclosed arrangements or unusual payment terms.
IBEX Limited ha segnalato la proposta di vendita di 10.000 azioni ordinarie tramite RBC Capital Markets, per un valore di mercato complessivo approssimativo di $300.013. La comunicazione indica che le azioni corrispondono a assegnazioni di azioni ricevute il 20/04/2022 dall'emittente e che la vendita 猫 prevista per il 22/08/2025 sul mercato NASDAQ. Il deposito riporta 13.372.404 azioni in circolazione e non segnala altre vendite da parte del dichiarante negli ultimi tre mesi. Il dichiarante inoltre afferma di non essere a conoscenza di informazioni riservate rilevanti non divulgate e richiama l'avviso legale relativo a dichiarazioni mendaci intenzionali.
IBEX Limited inform贸 una propuesta de venta de 10.000 acciones ordinarias a trav茅s de RBC Capital Markets, con un valor de mercado agregado aproximado de $300.013. La presentaci贸n indica que las acciones corresponden a concesiones de acciones recibidas el 20/04/2022 del emisor y que la venta est谩 prevista para el 22/08/2025 en NASDAQ. El informe muestra 13.372.404 acciones en circulaci贸n y no informa otras ventas por parte del declarante en los 煤ltimos tres meses. El presentador tambi茅n afirma no tener conocimiento de informaci贸n adversa material no divulgada y se帽ala la advertencia legal sobre declaraciones intencionalmente falsas.
IBEX Limited电� RBC Capital Markets毳� 韱淀暣 10,000 氤错喌欤�鞚� 毵り皝鞚� 鞝滌晥頄堨溂氅�, 齑� 鞁滌灔臧�旃樀鐢 鞎� $300,013鞚措澕瓿� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐惖鐢 頃措嫻 欤检嫕鞚� 氚滍枆靷攵�韯� 2022雲� 4鞗� 20鞚检棎 靾橂牴頃� 欤检嫕 攵�鞐�鞐� 頃措嫻頃橂┌, 毵り皝鞚� 2025雲� 8鞗� 22鞚� NASDAQ鞐愳劀 鞚措（鞏挫 鞓堨爼鞚措澕瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊电� 鞙犿喌欤检嫕靾橁皜 13,372,404欤�鞛勳潉 氤挫棳欤茧┌, 氤搓碃鞚胳棎 鞚橅暅 斓滉芳 3臧滌洈 雮� 雼るジ 毵り皝鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 鞝滌稖鞚胳潃 霕愴暅 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橁碃, 瓿犾潣鞝� 項堨渼歆勳垹鞐� 甏�頃� 氩曥爜 瓴疥碃毳� 鞏戈笁頄堨姷雼堧嫟.
IBEX Limited a d茅clar茅 la vente propos茅e de 10 000 actions ordinaires via RBC Capital Markets, pour une valeur marchande agr茅g茅e d'environ 300 013 $. Le d茅p么t indique que les actions correspondent 脿 des attributions d'actions re莽ues le 20/04/2022 de l'茅metteur et que la vente est pr茅vue le 22/08/2025 sur le NASDAQ. Le dossier fait 茅tat de 13 372 404 actions en circulation et n'enregistre aucune autre vente par la personne d茅clarante au cours des trois derniers mois. Le d茅clarant affirme 茅galement ne pas 锚tre au courant d'informations d茅favorables mat茅rielles non divulgu茅es et rappelle l'avertissement l茅gal concernant les fausses d茅clarations intentionnelles.
IBEX Limited meldete einen vorgeschlagenen Verkauf von 10.000 Stammaktien 眉产别谤 RBC Capital Markets mit einem ungef盲hren Gesamtkurswert von $300.013. Die Einreichung gibt an, dass die Aktien Aktienschenkungen vom 20.04.2022 des Emittenten darstellen und der Verkauf voraussichtlich am 22.08.2025 an der NASDAQ stattfinden wird. Die Meldung weist 13.372.404 ausstehende Aktien aus und berichtet 眉产别谤 keine weiteren Verk盲ufe der meldenden Person in den letzten drei Monaten. Der Melder best盲tigt au脽erdem, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und weist auf die rechtliche Warnung betreffend vors盲tzliche Falschangaben hin.
FAQ
What is being reported in the IBEX (IBEX) Form 144?
How were the shares being sold acquired according to the filing?
What percentage of outstanding shares does this sale represent for IBEX?
Was the filer reported to have sold any IBEX securities in the past three months?
On which exchange is the proposed sale expected to occur?
